PharmEnable Therapeutics Revenue

Biotechnology Research • Cambridge, England, United Kingdom • 11-20 Employees

PharmEnable Therapeutics revenue & valuation

Annual revenue	$1,000,000
Revenue per employee	$63,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,200,000
Total funding	$7,500,000

Key Contacts at PharmEnable Therapeutics

James Dale

Director Of Chemistry

David Vidal

Chief Technology Officer

Natalia Mateu

Founder / Cso

Kyla Grimshaw

Director Of Biology

Company overview

Headquarters	Compass House, Vision Park, Histon, Cambridge, Cambridgeshire CB24 9AD, GB
Website	pharmenabletx.com
NAICS	541714
Employees	11-20
Socials

PharmEnable Therapeutics Email Formats

PharmEnable Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@pharmenabletx.com), used 78.6% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@pharmenabletx.com	78.6%
{first name}.{last name}	john.doe@pharmenabletx.com	21.4%

About PharmEnable Therapeutics

PharmEnable is a biopharmaceutical company utilizing AI to discover effective small-molecule medicines for disease targets that are inaccessible to antibodies. With our proprietary AI-enabled drug discovery platform, chemSEEK, we explore new chemical spaces and discover novel small molecules with antibody-like specificity and selectivity. We are developing a pipeline of wholly owned therapeutics with initial focus on oncology and neurology. We also engage in drug discovery partnerships across a range of disease areas where accessing the target poses a significant challenge. PharmEnable is based in Cambridge, UK, and is a spinoff of the University of Cambridge. Discover how we are reimagining small molecule therapeutics through AI at pharmenabletx.com and connect with us on LinkedIn.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

C-Suite

Director

Entry

Employees by Department

PharmEnable Therapeutics has 6 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore PharmEnable Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-06-22	3	$7,500,000

Funding Insights

$7,500,000

Total funding amount

$7,500,000

Most recent funding amount

Number of funding rounds

PharmEnable Therapeutics Tech Stack

Discover the technologies and tools that power PharmEnable Therapeutics's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

SiteGround

Hosting

Swiper

JavaScript libraries

Moove GDPR Consent

Cookie compliance

Microsoft 365

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Divi

Page builders

Google Analytics

Analytics

Yoast SEO

SEO

Frequently asked questions

PharmEnable Therapeutics is located in Cambridge, England, GB.

PharmEnable Therapeutics generates an estimated annual revenue of $1,000,000. This revenue figure reflects the company's market position and business performance in its industry.

PharmEnable Therapeutics has an estimated valuation of $3,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

PharmEnable Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

PharmEnable Therapeutics has raised a total of $7,500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at PharmEnable Therapeutics

James Dale

Director Of Chemistry

David Vidal

Chief Technology Officer

Natalia Mateu

Founder / Cso

Kyla Grimshaw

Director Of Biology

4.8

40,000 users